SAMHSA Told States to Prepare for Psychedelic Medicines Before FDA Approval. South Dakota Already Wrote a Psilocybin Trigger—and Still Has Not Answered Federal Cannabis Schedule III.

In August 2026, the Substance Abuse and Mental Health Services Administration published a policy paper telling state and territorial mental-health systems to start planning now for the fiscal, legal, and operational consequences of possible FDA-approved psychedelic therapies.¹ The paper is not a regulation. It does not approve psilocybin, MDMA, or LSD. It tells states to … Continue reading SAMHSA Told States to Prepare for Psychedelic Medicines Before FDA Approval. South Dakota Already Wrote a Psilocybin Trigger—and Still Has Not Answered Federal Cannabis Schedule III.